QT interval monitoring for inpatient treated with hydroxychloroquine/azithromycin association in the context of SARS-CoV-2 pandemic

BACKGROUND: There are ongoing clinical trials on the efficacy of several therapeutic strategies for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Among them, the association between hydroxychloroquine (HCQ) and azithromycin (AZT) is under evaluation. Both drugs have a known torsa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bun, S., Courjon, J., Squara, F., Scarlatti, D., Sartre, B., Labbaoui, M., Drici, M., Ferrari, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS 2021
Materias:
031
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719938/
http://dx.doi.org/10.1016/j.acvdsp.2020.10.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719938/
http://dx.doi.org/10.1016/j.acvdsp.2020.10.229

Ejemplares similares